BCLI
HighTower Advisors’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,250
| Closed | -$3K | – | 3314 |
|
|
2023
Q4 | $3K | Sell |
10,250
-215
| -2% | -$63 | ﹤0.01% | 3345 |
|
|
2023
Q3 | $2K | Buy |
+10,465
| New | +$2K | ﹤0.01% | 3304 |
|
|
2021
Q2 | – | Sell |
-10,516
| Closed | -$40K | – | 2912 |
|
|
2021
Q1 | $40K | Buy |
+10,516
| New | +$40K | ﹤0.01% | 2790 |
|
|
2019
Q4 | – | Sell |
-10,266
| Closed | -$40K | – | 2216 |
|
|
2019
Q3 | $40K | Hold |
10,266
| – | – | ﹤0.01% | 2207 |
|
|
2019
Q2 | $41K | Sell |
10,266
-500
| -5% | -$2K | ﹤0.01% | 2193 |
|
|
2019
Q1 | $46K | Hold |
10,766
| – | – | ﹤0.01% | 2102 |
|
|
2018
Q4 | $39K | Hold |
10,766
| – | – | ﹤0.01% | 2012 |
|
|
2018
Q3 | $41K | Hold |
10,766
| – | – | ﹤0.01% | 2104 |
|
|
2018
Q2 | $42K | Hold |
10,766
| – | – | ﹤0.01% | 2051 |
|
|
2018
Q1 | $35K | Hold |
10,766
| – | – | ﹤0.01% | 2005 |
|
|
2017
Q4 | $42K | Buy |
10,766
+500
| +5% | +$1.95K | ﹤0.01% | 2086 |
|
|
2017
Q3 | $42K | Hold |
10,266
| – | – | ﹤0.01% | 2076 |
|
|
2017
Q2 | $43K | Sell |
10,266
-500
| -5% | -$2.09K | ﹤0.01% | 2023 |
|
|
2017
Q1 | $46K | Hold |
10,766
| – | – | ﹤0.01% | 1914 |
|
|
2016
Q4 | $27K | Hold |
10,766
| – | – | ﹤0.01% | 1839 |
|
|
2016
Q3 | $26K | Hold |
10,766
| – | – | ﹤0.01% | 1808 |
|
|
2016
Q2 | $26K | Hold |
10,766
| – | – | ﹤0.01% | 1664 |
|
|
2016
Q1 | $29K | Buy |
+10,766
| New | +$29K | ﹤0.01% | 1905 |
|
|
2015
Q2 | – | Sell |
-12,266
| Closed | -$54K | – | 1573 |
|
|
2015
Q1 | $54K | Buy |
12,266
+2,000
| +19% | +$8.81K | ﹤0.01% | 1535 |
|
|
2014
Q4 | $49K | Buy |
+10,266
| New | +$49K | ﹤0.01% | 1506 |
|